These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3647541)

  • 1. [Visceral leishmaniasis associated with positive anti-HTLV III antibody].
    Verdejo J; Alvar J; Polo RM; González Lahoz JM
    Rev Clin Esp; 1987 Mar; 180(4):221. PubMed ID: 3647541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 3. [Visceral leishmaniasis in patients addicted to parenteral drugs, HIV positive].
    Martínez Fernández R; García Díaz JD; Gutiérrez Sánchez J; Riopérez Carmena E; Valdivieso Varela L; Alonso Navas F
    Med Clin (Barc); 1987 Mar; 88(12):509-11. PubMed ID: 3586728
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies anti-HTLV III and lymphocyte subsets of high risk subjects.
    Ripa S; Mignini F; Anichini M; Casprini P; Prenna M
    Boll Ist Sieroter Milan; 1987; 66(2):101-5. PubMed ID: 3663335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Visceral leishmaniasis associated with HIV infection].
    Rivero A; Santos J; Márquez M; Gavilán JC; Carralero C
    Enferm Infecc Microbiol Clin; 1989 Jan; 7(1):59-60. PubMed ID: 2490650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Visceral leishmaniasis in a patient with HIV-2 infection].
    Sarmento e Castro R; Horta AA; Vasconcelos O; Coelho H; Granato C; Rocha Marques A
    Rev Clin Esp; 1995 Aug; 195(8):591-2. PubMed ID: 7569213
    [No Abstract]   [Full Text] [Related]  

  • 7. [Visceral leishmaniasis and HIV infection: 3 new cases].
    Laguna Cuesta F; García Aguado C; Puente Puente S; Mateu París B
    Rev Clin Esp; 1989 Mar; 184(5):267-8. PubMed ID: 2772301
    [No Abstract]   [Full Text] [Related]  

  • 8. [Visceral leishmaniasis in patients infected with HIV in the Barcelona area].
    Galofré J; Miró JM; Mallolas J; García-Ruz F; Grau JM
    Rev Clin Esp; 1990 Jun; 187(2):98-9. PubMed ID: 2244070
    [No Abstract]   [Full Text] [Related]  

  • 9. [Visceral leishmaniasis and AIDS. Report of 2 cases with cutaneous dissemination].
    Belda Mira A; Díaz Sánchez F; Martínez García B; Gonzalvo Bellver E; Antón Crespo V; Redón Mas J
    An Med Interna; 1994 Aug; 11(8):398-400. PubMed ID: 7772689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 11. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 12. [Leishmaniasis associated with acquired immunodeficiency syndrome].
    Franco-Vicario R; Beltrán de Heredia JM; Rojo P; Hermosa C
    Med Clin (Barc); 1987 Apr; 88(14):565-6. PubMed ID: 3586756
    [No Abstract]   [Full Text] [Related]  

  • 13. [AIDS: detection of the HTLV-III-antibody].
    Med Monatsschr Pharm; 1986 Sep; 9(9):277-8. PubMed ID: 3464819
    [No Abstract]   [Full Text] [Related]  

  • 14. [Visceral leishmaniasis of fatal outcome associated with HTLV-III infection].
    Medrano González F; Alemán Lorenzo A; Beato Pérez JL
    Med Clin (Barc); 1986 Nov; 87(18):780-1. PubMed ID: 3796128
    [No Abstract]   [Full Text] [Related]  

  • 15. [Occurrence of HTLV-III infection and related clinical forms in a homogeneous group of drug addicts. Significance of immunologic changes and evaluation of risk factors].
    Tassinari MC; Gualandi M; Guerra G; Barbieri D; Benassi N; Lazzarato M; Dallara G; Gallerani M
    Recenti Prog Med; 1986 Oct; 77(10):461-5. PubMed ID: 3547522
    [No Abstract]   [Full Text] [Related]  

  • 16. Digestive leishmaniasis in acquired immunodeficiency syndrome: a light and electron microscopic study of two cases.
    Zimmer G; Guillou L; Gauthier T; Iten A; Saraga EP
    Mod Pathol; 1996 Oct; 9(10):966-9. PubMed ID: 8902832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic generalized lymphadenopathy with splenomegaly associated with HTLV-III virus antibodies].
    Mijović A; Stevanović G; Brkić S; Dimitrijević M; Rolović Z; Ruvidić R
    Srp Arh Celok Lek; 1986 Jan; 114(1):109-20. PubMed ID: 3014667
    [No Abstract]   [Full Text] [Related]  

  • 18. [Visceral leishmaniasis and acquired immunodeficiency syndrome].
    Vallespí T; Torrabadella M; Irriguible D; Ocaña I; Martínez-Vázquez JM; Orriols R; de Gracia J; Gasser I; Portús M
    Sangre (Barc); 1989 Jun; 34(3):241-3. PubMed ID: 2788313
    [No Abstract]   [Full Text] [Related]  

  • 19. [Visceral leishmaniasis and immunosuppression].
    Lortholary O; Christiaens D; Mechali D; Babinet P
    Ann Med Interne (Paris); 1991; 142(3):215-7. PubMed ID: 1854134
    [No Abstract]   [Full Text] [Related]  

  • 20. Visceral leishmaniasis and AIDS.
    de Gorgolas M; Miles MA
    Nature; 1994 Dec 22-29; 372(6508):734. PubMed ID: 7997260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.